Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.58 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | PLG | P00747 | 1/20 | 0.48 |
| ▸ | PLAT | P00750 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL147243 | 1.00 | ACE (0.58) | ACEGABRR1AKR1C3AKR1C1LMNA | |
| SCHEMBL20828352 | 1.00 | ACE (0.58) | ACEGABRR1AKR1C3AKR1C1LMNA | |
| SCHEMBL1286869 | 1.00 | ACE (0.58) | ACEGABRR1AKR1C3AKR1C1LMNA | |
| SCHEMBL22001630 | 1.00 | ACE (0.58) | ACEGABRR1AKR1C3AKR1C1LMNA | |
| SCHEMBL110580 | 1.00 | ACE (0.58) | ACEGABRR1AKR1C3AKR1C1LMNA | |
| SCHEMBL24906952 | 1.00 | ACE (0.58) | ACEGABRR1AKR1C3AKR1C1LMNA | |
| Hydrochloric Acid SCHEMBL4372281 | 0.97 | ACE (0.56) | ACEGABRR1AKR1C3AKR1C1LMNA | |
| SCHEMBL11544105 | 0.97 | ACE (0.56) | ACEGABRR1AKR1C3AKR1C1LMNA | |
| Bromide SCHEMBL9180235 | 0.97 | ACE (0.56) | ACEGABRR1AKR1C3AKR1C1LMNA | |
| SCHEMBL11133443 | 0.97 | ACE (0.56) | ACEGABRR1AKR1C3AKR1C1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 498 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113754871-B | Biodegradable block copolyesters based on lactide- (cycloaliphatic-co-aromatic) -lactide | 浙江恒逸石化研究院有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-113698585-B | Biodegradable glycolide- (alicyclic-co-preparation method of aromatic) -glycolide block copolyesters | 浙江恒逸石化研究院有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-113754871-A | Biodegradable block copolyester based on lactide- (alicyclic-co-aromatic) -lactide | 浙江恒澜科技有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-113698585-A | Preparation method of biodegradable glycolide- (alicyclic-co-aromatic) -glycolide block copolyester | 浙江恒澜科技有限公司 | 2021-11-26 | — | — | CN | claimed |
| EP-3609990-B1 | POLYMERS AS ADDITIVES FOR FUELS AND LUBRICANTS | BASF SE (DE) | 2021-10-27 | — | — | EP | claimed |
| EP-3609990-A1 | POLYMERS AS ADDITIVES FOR FUELS AND LUBRICANTS | BASF SE (DE) | 2020-02-19 | — | — | EP | claimed |
| US-10179891-B2 | Use of branched polyesters based on citric acid as additive in washing compositions, detergents or a formulation for water treatment | BASF SE (DE) | 2019-01-15 | — | — | US | claimed |
| EP-2721090-B1 | BRANCHED POLYESTERS WITH SULFONATE GROUPS | BASF SE (DE) | 2015-09-09 | — | — | EP | claimed |
| EP-2721089-B1 | BRANCHED POLYESTERS WITH SULFONATE GROUPS | BASF SE (DE) | 2015-08-12 | — | — | EP | claimed |
| US-8846599-B2 | Branched polyesters with sulfonate groups | BASF SE (DE) | 2014-09-30 | — | — | US | claimed |
| US-20120322950-A1 | BRANCHED POLYESTERS WITH SULFONATE GROUPS | BASF SE (DE) | 2012-12-20 | — | — | US | claimed |
| US-20120322714-A1 | BRANCHED POLYESTERS WITH SULFONATE GROUPS | BASF SE (DE) | 2012-12-20 | — | — | US | claimed |
| EP-2155162-B1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB (US) | 2012-11-21 | — | — | EP | claimed |
| EP-2155162-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | Bausch & Lomb Incorporated (US) | 2010-02-24 | — | — | EP | claimed |
| US-20080280853-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED | 2008-11-13 | — | — | US | claimed |
| WO-2008137496-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | BAUSCH & LOMB INCORPORATED (US) | 2008-11-13 | — | — | WO | claimed |
| US-20080275000-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | SALIX PHARMACEUTICALS, INC. | 2008-11-06 | — | — | US | claimed |
| EP-0543264-B1 | Rewritable thermosensitive recording medium | TOPPAN PRINTING CO LTD (JP) | 1995-05-03 | — | — | EP | claimed |
| US-5278129-A | Low molecular weight alicyclic dicarboxylic acid | TOPPAN PRINTING CO., LTD. (JP) | 1994-01-11 | — | — | US | claimed |
| EP-0543264-A1 | Rewritable thermosensitive recording medium | Toppan Printing Co., Ltd. (JP) | 1993-05-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275000-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | PDE6D, PDE6H, CA2 | ACE 1039/4885GABRR1 262/4885AKR1C3 444/4885 |
| US-20080280853-A1 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | CA2, IDUA, CA6 | ACE 489/4885GABRR1 1142/4885AKR1C3 602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.